News & Updates
Filter by Specialty:
MV130 immunotherapy prevents COPD exacerbations
24 Sep 2021
byElaine Soliven
Treatment with MV130, a sublingual bacterial immunotherapy, reduces the number of exacerbations in patients with chronic obstructive pulmonary disease (COPD), according to a recent study presented at ERS 2021.